These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 32543949)

  • 41. Review of current treatment in panic disorder.
    den Boer JA; Slaap BR
    Int Clin Psychopharmacol; 1998 Apr; 13 Suppl 4():S25-30. PubMed ID: 9690962
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sertraline and venlafaxine: new indication. Prevention of recurrent depression: no advance.
    Prescrire Int; 2005 Feb; 14(75):19-20. PubMed ID: 15751171
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy in long-term treatment of depression.
    Montgomery SA
    J Clin Psychiatry; 1996; 57 Suppl 2():24-30. PubMed ID: 8626360
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Consensus statement on panic disorder from the International Consensus Group on Depression and Anxiety.
    Ballenger JC; Davidson JR; Lecrubier Y; Nutt DJ; Baldwin DS; den Boer JA; Kasper S; Shear MK
    J Clin Psychiatry; 1998; 59 Suppl 8():47-54. PubMed ID: 9707162
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evidence-based pharmacotherapy of panic disorder.
    Bakker A; van Balkom AJ; Stein DJ
    Int J Neuropsychopharmacol; 2005 Sep; 8(3):473-82. PubMed ID: 15804373
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Medication discontinuation in panic disorder.
    Ballenger JC
    J Clin Psychiatry; 1992 Mar; 53 Suppl():26-31. PubMed ID: 1548252
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evidence that patients with single versus recurrent depressive episodes are differentially sensitive to treatment discontinuation: a meta-analysis of placebo-controlled randomized trials.
    Kaymaz N; van Os J; Loonen AJ; Nolen WA
    J Clin Psychiatry; 2008 Sep; 69(9):1423-36. PubMed ID: 19193343
    [TBL] [Abstract][Full Text] [Related]  

  • 48. WCA recommendations for the long-term treatment of panic disorder.
    Pollack MH; Allgulander C; Bandelow B; Cassano GB; Greist JH; Hollander E; Nutt DJ; Okasha A; Swinson RP;
    CNS Spectr; 2003 Aug; 8(8 Suppl 1):17-30. PubMed ID: 14767395
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis.
    Bauer M; Tharmanathan P; Volz HP; Moeller HJ; Freemantle N
    Eur Arch Psychiatry Clin Neurosci; 2009 Apr; 259(3):172-85. PubMed ID: 19165525
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacological treatment options for panic disorder in children and adolescents.
    Masi G; Pari C; Millepiedi S
    Expert Opin Pharmacother; 2006 Apr; 7(5):545-54. PubMed ID: 16553570
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorder.
    Pollack M; Mangano R; Entsuah R; Tzanis E; Simon NM; Zhang Y
    Psychopharmacology (Berl); 2007 Oct; 194(2):233-42. PubMed ID: 17589833
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.
    Soares-Weiser K; Bravo Vergel Y; Beynon S; Dunn G; Barbieri M; Duffy S; Geddes J; Gilbody S; Palmer S; Woolacott N
    Health Technol Assess; 2007 Oct; 11(39):iii-iv, ix-206. PubMed ID: 17903393
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Developments in the drug treatment of panic disorder: what is the place of the selective serotonin reuptake inhibitors?
    Westenberg HG
    J Affect Disord; 1996 Sep; 40(1-2):85-93. PubMed ID: 8882918
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SSRIs versus non-SSRIs in post-traumatic stress disorder: an update with recommendations.
    Asnis GM; Kohn SR; Henderson M; Brown NL
    Drugs; 2004; 64(4):383-404. PubMed ID: 14969574
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Selective serotonin reuptake inhibitors in the treatment of post-traumatic stress disorder: a meta-analysis of randomized controlled trials.
    Stein DJ; Seedat S; van der Linden GJ; Zungu-Dirwayi N
    Int Clin Psychopharmacol; 2000 Aug; 15 Suppl 2():S31-9. PubMed ID: 11110017
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Citalopram therapy for depression: a review of 10 years of European experience and data from U.S. clinical trials.
    Keller MB
    J Clin Psychiatry; 2000 Dec; 61(12):896-908. PubMed ID: 11206593
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fluoxetine versus other types of pharmacotherapy for depression.
    Magni LR; Purgato M; Gastaldon C; Papola D; Furukawa TA; Cipriani A; Barbui C
    Cochrane Database Syst Rev; 2013 Jul; (7):CD004185. PubMed ID: 24353997
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Panic disorder.
    Kumar S; Oakley-Browne M
    Clin Evid; 2002 Jun; (7):906-12. PubMed ID: 12230714
    [No Abstract]   [Full Text] [Related]  

  • 59. Time to relapse after 6 and 12 months' treatment of generalized anxiety disorder with venlafaxine extended release.
    Rickels K; Etemad B; Khalid-Khan S; Lohoff FW; Rynn MA; Gallop RJ
    Arch Gen Psychiatry; 2010 Dec; 67(12):1274-81. PubMed ID: 21135327
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Current pharmacological interventions in panic disorder.
    Freire RC; Machado S; Arias-Carrión O; Nardi AE
    CNS Neurol Disord Drug Targets; 2014; 13(6):1057-65. PubMed ID: 24923349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.